Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.

Coppola GM, Kukkola PJ, Stanton JL, Neubert AD, Marcopulos N, Bilci NA, Wang H, Tomaselli HC, Tan J, Aicher TD, Knorr DC, Jeng AY, Dardik B, Chatelain RE.

J Med Chem. 2005 Oct 20;48(21):6696-712.

PMID:
16220986
2.

Glucocorticoid receptor antagonism by cyproterone acetate and RU486.

Honer C, Nam K, Fink C, Marshall P, Ksander G, Chatelain RE, Cornell W, Steele R, Schweitzer R, Schumacher C.

Mol Pharmacol. 2003 May;63(5):1012-20.

PMID:
12695529
3.
4.

Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.

Chatelain RE, Ghai RD, Trapani AJ, Odorico LM, Dardik BN, De Lombaert S, Lappe RW, Fink CA.

J Pharmacol Exp Ther. 1998 Mar;284(3):974-82.

PMID:
9495857
5.
6.

Antihypertensive effects of CGS 19281A, an inhibitor of phenylethanolamine-N-methyltransferase.

Chatelain RE, Manniello MJ, Dardik BN, Rizzo M, Brosnihan KB.

J Pharmacol Exp Ther. 1990 Jan;252(1):117-25.

PMID:
2153796
7.

Malignant hypertension, fibrinoid deposition, and fibrinogen electrophoresis.

Dardik BN, Shainoff JR, Chatelain RE, DiBello PM, Ferrario CM.

Cleve Clin J Med. 1989 Jun;56(4):451-6. Review.

PMID:
2663231
8.

Elevated arterial cyclic AMP levels during the development of one-kidney, one-clip and DOCA hypertension in rats.

Dardik BN, DiBello PM, Chatelain RE.

Eur J Pharmacol. 1988 Dec 6;158(1-2):139-43.

PMID:
2851454
9.

Increased DNA replication in the arterial adventitia after aortic ligation.

Chatelain RE, Dardik BN.

Hypertension. 1988 Feb;11(2 Pt 2):I130-4.

PMID:
3346048
10.

Elevated plasma catecholamines and adrenal phenylethanolamine N-methyl transferase in experimental renal hypertension.

Chatelain RE, Bridle PA, Manniello MJ, Dardik BN.

J Hypertens Suppl. 1986 Dec;4(6):S240-3.

PMID:
3302151
11.

Elevated arterial cyclic AMP levels during the development of spontaneous hypertension in rats.

Chatelain RE, Dardik BN, Robson RD.

Eur J Pharmacol. 1985 Jun 7;112(2):271-5.

PMID:
2993002
13.

Elevated arterial cyclic AMP levels during the onset of renal hypertension in rats.

Chatelain RE.

Clin Sci (Lond). 1983 Mar;64(3):355-8.

PMID:
6295692
14.
15.

Impaired arterial collagen and elastin metabolism in experimental malignant hypertension.

Chatelain RE, Ehrhart LA, DiBello PM, Dardik BN, Ferrario CM.

J Lab Clin Med. 1981 May;97(5):700-17. No abstract available.

PMID:
7012254
16.

Experimental benign and malignant hypertension with malignant nephrosclerosis.

Chatelain RE, DiBello PM, Ferrario CM.

Br J Exp Pathol. 1980 Aug;61(4):401-10. No abstract available.

17.

Development of two-kidney Goldblatt hypertension in rats under dietary sodium restriction.

Muñoz-Ramírez H, Chatelain RE, Bumpus FM, Khairallah PA.

Am J Physiol. 1980 Jun;238(6):H889-94.

PMID:
6992601
18.

Lymphoid alterations and impaired T lymphocyte reactivity in experimental renal hypertension.

Chatelain RE, Vessey AR, Ferrario CM.

J Lab Clin Med. 1980 May;95(5):737-47.

PMID:
6988532
19.

Biphasic changes in thymus structure during evolving renal hypertension.

Chatelain RE, Ferrario CM.

Clin Sci Mol Med. 1978 Aug;55(2):149-56.

PMID:
679625

Supplemental Content

Loading ...
Support Center